Consensus Daxor Corporation NYSE

Stocks

DXR

US2394671034

Closed End Funds

Market Closed - NYSE 21:30:00 18/09/2026 BST			5-day change	1st Jan Change
11.45 ^USD	-1.55%		-0.17%	-22.37%

08-31	Daxor Corporation Reports Earnings Results for the Half Year Ended June 30, 2026	CI
07-30	Daxor Launches Blood Testing Lab in Eastern Kansis	MT

6d2c8cc2f3c231949ce0169a44.WYIWJJqZDbvxXUJv0Yo3APRTJ7C5l_t73B-JXsBCRnA.EPZgTPP1POmiOjhC5MtUdYIxQ_Xo1akxqV3GMI43CwRvzSd0ytxrwaIFIQ~2a23a9c6b7092203d242f6da14591761

Closed End Funds

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
3I INFRASTRUCTURE PLC			+6.28%
PERSHING SQUARE USA, LTD.	-	-	+8.84%
Average			+7.56%
Weighted average by Cap.			+7.41%

See all sector performances

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

11.45USD

Average target price

20.00USD

Spread / Average Target

+74.67%

High Price Target

22.00USD

Spread / Highest target

+92.14%

Low Price Target

18.00USD

Spread / Lowest Target

+57.21%

Consensus Daxor Corporation NYSE

Stocks

DXR

US2394671034

Closed End Funds

Evolution of the Average Target: Daxor Corporation

Evolution of the Target Price: Daxor Corporation

Changes in Analyst Recommendations: Daxor Corporation

Closed End Funds

Analysts' Consensus

Analyst Consensus Detail

Consensus revision (last 18 months)